Evidence map›Paper›PMID 37365163›Full record

ArticleNature communications2023

NOD1 mediates interleukin-18 processing in epithelial cells responding to Helicobacter pylori infection in mice.

L S Tran, L Ying, K D'Costa, G Wray-McCann, G Kerr, L Le, C C Allison, J Ferrand, H Chaudhry, J Emery and 17 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of Nod-like Receptors inMicroorganisms · 2026
    Review
  4. Review
  5. Article
  6. IL-1 family of cytokines in gastrointestinal and liver disorders.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  7. Review
  8. Pyroptosis in gastric mucosal injury‑related diseases (Review).International journal of molecular medicine · 2025
    Review
  9. Therapeutic Effects of Sulforaphane onInternational journal of molecular sciences · 2025
    Article
  10. International journal of molecular sciences · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. NOD1: a metabolic modulator.Frontiers in endocrinology · 2024
    Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 8 institutions in 4 countries.

L S TranCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
L YingCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0000-0002-8178-7874
K D'CostaCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0000-0002-8989-9723
G Wray-McCannCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0009-0005-3156-9392
G KerrDepartment of Anatomy and Developmental Biology, Development and Stem Cells Program, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia.ORCID 0000-0002-2166-6210
L LeCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
C C AllisonCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
J FerrandCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
H ChaudhryCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
J EmeryCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
A De PaoliCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
N ColonCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0000-0002-0112-975X
S CreedMonash Micro Imaging, Monash University, Melbourne, VIC, Australia.ORCID 0000-0003-4744-9924
M Kaparakis-LiaskosCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0000-0002-8964-4456
J ComoCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0000-0003-0620-9457
J K DowlingCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0000-0003-2842-1504
P A JohanesenDepartment of Microbiology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia.ORCID 0000-0001-5361-5074
T A KuferDepartment of Immunology, University of Hohenheim, Institute of Nutritional Medicine, Stuttgart, Germany.ORCID 0000-0003-4563-0412
J S PedersenTissuPath, Melbourne, VIC, Australia.
A MansellCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia.ORCID 0000-0002-6540-1281
D J PhilpottDepartment of Immunology, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-3238-6254
K D ElgassMonash Micro Imaging, Monash University, Melbourne, VIC, Australia.
H E AbudDepartment of Anatomy and Developmental Biology, Development and Stem Cells Program, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia.ORCID 0000-0003-3792-4023
U NachburCell Signalling and Cell Death Division, WEHI, Melbourne, VIC, Australia.
B A CrokerBoston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-0885-3599
S L MastersInflammation Division, WEHI, Melbourne, VIC, Australia.ORCID 0000-0003-4763-576X
R L FerreroCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia. Richard.Ferrero@Hudson.org.au.ORCID 0000-0001-6817-6211
Hudson Institute of Medical Research · AUMonash University · AUAustralian Regenerative Medicine Institute · AUBoston Children's Hospital · USDiscovery Institute · USTissuPath · AUUniversity of Hohenheim · DEUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interleukin-1 family members, IL-1β and IL-18, are processed into their biologically active forms by multi-protein complexes, known as inflammasomes. Although the inflammasome pathways that mediate IL-1β processing in myeloid cells have been defined, those involved in IL-18 processing, particularly in non-myeloid cells, are still not well understood. Here we report that the host defence molecule NOD1 regulates IL-18 processing in mouse epithelial cells in response to the mucosal pathogen, Helicobacter pylori. Specifically, NOD1 in epithelial cells mediates IL-18 processing and maturation via interactions with caspase-1, instead of the canonical inflammasome pathway involving RIPK2, NF-κB, NLRP3 and ASC. NOD1 activation and IL-18 then help maintain epithelial homoeostasis to mediate protection against pre-neoplastic changes induced by gastric H. pylori infection in vivo. Our findings thus demonstrate a function for NOD1 in epithelial cell production of bioactive IL-18 and protection against H. pylori-induced pathology.

Indexed as

Epithelial CellsHelicobacter InfectionsInterleukin-18Nod1 Signaling Adaptor ProteinAnimalsHelicobacter pyloriInflammasomesInterleukin-1betaMiceNLR Family, Pyrin Domain-Containing 3 ProteinSignal TransductionInflammasomesInterleukin-18Interleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinNod1 protein, mouseNod1 Signaling Adaptor Protein

Identifiers

PMID37365163
PMCPMC10293252
OpenAlexW4382138646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.